Safety, Tolerability, Pharmacokinetics and Efficacy of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors: A Multicenter, Open-label, Phase I Dose-escalation and Dose-expansion Study
Latest Information Update: 14 Feb 2024
Price :
$35 *
At a glance
- Drugs Mitoxantrone liposomal (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 07 Feb 2024 Status changed from not yet recruiting to completed.
- 16 Jun 2021 New trial record